Assignee
NALPROPION PHARMACEUTICALS LLC
US·7 granted patents·12 pending applications·29 citations·filing 2019–2024
Top patents by PatentIndex Score
19 records- 0195US12048769B2Methods for administering weight loss medicationsNALPROPION PHARMACEUTICALS LLC·Filed 2020·Granted Jul 30, 2024·3 cites·20 claims
- 0295US11998542B2Compositions and methods for reducing major adverse cardiovascular eventsNALPROPION PHARMACEUTICALS LLC·Filed 2020·Granted Jun 4, 2024·3 cites·20 claims
- 0393US11278544B2Compositions for affecting weight lossNALPROPION PHARMACEUTICALS LLC·Filed 2019·Granted Mar 22, 2022·4 cites·7 claims
- 0491US11139056B2Methods of treating overweight and obesityNALPROPION PHARMACEUTICALS LLC·Filed 2019·Granted Oct 5, 2021·4 cites·15 claims
- 0591US10835527B2Compositions and methods for reducing major adverse cardiovascular eventsNALPROPION PHARMACEUTICALS LLC·Filed 2019·Granted Nov 17, 2020·6 cites·20 claims
- 0691US10828294B2Compositions and methods for weight loss in at risk patient populationsNALPROPION PHARMACEUTICALS LLC·Filed 2019·Granted Nov 10, 2020·6 cites·20 claims
- 0790US11033543B2Methods of providing weight loss therapy in patients with major depressionNALPROPION PHARMACEUTICALS LLC·Filed 2019·Granted Jun 15, 2021·3 cites·19 claims
- 0887US2025144089A1Compositions And Methods For Reducing Major Adverse Cardiovascular EventsNALPROPION PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0986US2024366513A1Methods For Administering Weight Loss MedicationsNALPROPION PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1084US2023301922A1Layered Pharmaceutical FormulationsNALPROPION PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1181US2022202808A1Compositions For Affecting Weight LossNALPROPION PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1274US2022233520A1Increasing Drug Bioavailability In Naltrexone TherapyNALPROPION PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1373US2021346469A1Compositions and Methods for Increasing Insulin SensitivityNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1473US2022105087A1Increasing Drug Bioavailability In Naltrexone TherapyNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1573US2021267968A1Compositions And Methods For Reducing Food CravingsNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1672US2022208327A1Methods Of Treating Overweight And ObesityNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1771US2022088007A1Increasing Drug Bioavailability In Naltrexone TherapyNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1871US2021299119A1Methods Of Providing Weight Loss Therapy In Patients With Major DepressionNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1959US2021283126A1Methods For Reducing Binge Or Compulsive EatingNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →